203 related articles for article (PubMed ID: 29850793)
1. Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma.
Chortis V; Taylor AE; Doig CL; Walsh MD; Meimaridou E; Jenkinson C; Rodriguez-Blanco G; Ronchi CL; Jafri A; Metherell LA; Hebenstreit D; Dunn WB; Arlt W; Foster PA
Endocrinology; 2018 Aug; 159(8):2836-2849. PubMed ID: 29850793
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide nucleotide transhydrogenase is required for brain mitochondrial redox balance under hampered energy substrate metabolism and high-fat diet.
Francisco A; Ronchi JA; Navarro CDC; Figueira TR; Castilho RF
J Neurochem; 2018 Dec; 147(5):663-677. PubMed ID: 30281804
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide Nucleotide Transhydrogenase Is Essential for Adrenal Steroidogenesis: Clinical and In Vitro Lessons.
Bodoni AF; Coeli-Lacchini FB; Gebenlian JL; Sobral LM; Garcia CB; Silva WA; Peronni KC; Ramalho LNZ; Ramalho FS; Moreira AC; de Castro M; Leopoldino AM; Antonini SRR
J Clin Endocrinol Metab; 2023 May; 108(6):1464-1474. PubMed ID: 36478070
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide nucleotide transhydrogenase (Nnt) links the substrate requirement in brain mitochondria for hydrogen peroxide removal to the thioredoxin/peroxiredoxin (Trx/Prx) system.
Lopert P; Patel M
J Biol Chem; 2014 May; 289(22):15611-20. PubMed ID: 24722990
[TBL] [Abstract][Full Text] [Related]
5. Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle.
Gameiro PA; Laviolette LA; Kelleher JK; Iliopoulos O; Stephanopoulos G
J Biol Chem; 2013 May; 288(18):12967-77. PubMed ID: 23504317
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide nucleotide transhydrogenase (NNT) deficiency dysregulates mitochondrial retrograde signaling and impedes proliferation.
Ho HY; Lin YT; Lin G; Wu PR; Cheng ML
Redox Biol; 2017 Aug; 12():916-928. PubMed ID: 28478381
[TBL] [Abstract][Full Text] [Related]
7. NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice.
Meimaridou E; Goldsworthy M; Chortis V; Fragouli E; Foster PA; Arlt W; Cox R; Metherell LA
J Endocrinol; 2018 Jan; 236(1):13-28. PubMed ID: 29046340
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial NAD(P)
Francisco A; Figueira TR; Castilho RF
Antioxid Redox Signal; 2022 May; 36(13-15):864-884. PubMed ID: 34155914
[No Abstract] [Full Text] [Related]
9. The Contribution of Nicotinamide Nucleotide Transhydrogenase to Peroxide Detoxification Is Dependent on the Respiratory State and Counterbalanced by Other Sources of NADPH in Liver Mitochondria.
Ronchi JA; Francisco A; Passos LA; Figueira TR; Castilho RF
J Biol Chem; 2016 Sep; 291(38):20173-87. PubMed ID: 27474736
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide nucleotide transhydrogenase (NNT) regulates mitochondrial ROS and endothelial dysfunction in response to angiotensin II.
Rao KNS; Shen X; Pardue S; Krzywanski DM
Redox Biol; 2020 Sep; 36():101650. PubMed ID: 32763515
[TBL] [Abstract][Full Text] [Related]
11. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency.
Meimaridou E; Kowalczyk J; Guasti L; Hughes CR; Wagner F; Frommolt P; Nürnberg P; Mann NP; Banerjee R; Saka HN; Chapple JP; King PJ; Clark AJ; Metherell LA
Nat Genet; 2012 May; 44(7):740-2. PubMed ID: 22634753
[TBL] [Abstract][Full Text] [Related]
12. NNT reverse mode of operation mediates glucose control of mitochondrial NADPH and glutathione redox state in mouse pancreatic β-cells.
Santos LRB; Muller C; de Souza AH; Takahashi HK; Spégel P; Sweet IR; Chae H; Mulder H; Jonas JC
Mol Metab; 2017 Jun; 6(6):535-547. PubMed ID: 28580284
[TBL] [Abstract][Full Text] [Related]
13. Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R.
Gaujoux S; Hantel C; Launay P; Bonnet S; Perlemoine K; Lefèvre L; Guillaud-Bataille M; Beuschlein F; Tissier F; Bertherat J; Rizk-Rabin M; Ragazzon B
PLoS One; 2013; 8(2):e55743. PubMed ID: 23409032
[TBL] [Abstract][Full Text] [Related]
14. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition.
Salomon A; Keramidas M; Maisin C; Thomas M
Oncotarget; 2015 May; 6(13):11421-33. PubMed ID: 25823656
[TBL] [Abstract][Full Text] [Related]
15. Flux through mitochondrial redox circuits linked to nicotinamide nucleotide transhydrogenase generates counterbalance changes in energy expenditure.
Smith CD; Schmidt CA; Lin CT; Fisher-Wellman KH; Neufer PD
J Biol Chem; 2020 Nov; 295(48):16207-16216. PubMed ID: 32747443
[TBL] [Abstract][Full Text] [Related]
16. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
[TBL] [Abstract][Full Text] [Related]
17. Lack of NAD(P)+ transhydrogenase activity in patients with primary adrenal insufficiency due to NNT variants.
Francisco A; Goler AMY; Navarro CDC; Onder A; Yildiz M; Kendir Demirkol Y; Karademir Yilmaz B; Seven Menevse T; Güran T; Castilho RF
Eur J Endocrinol; 2024 Feb; 190(2):130-138. PubMed ID: 38261461
[TBL] [Abstract][Full Text] [Related]
18. Toward a pathway-centered approach for the treatment of adrenocortical carcinoma.
Bussey KJ; Demeure MJ
Curr Opin Oncol; 2011 Jan; 23(1):34-44. PubMed ID: 21045685
[TBL] [Abstract][Full Text] [Related]
19. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression.
Chen D; Shen Z; Cheng X; Wang Q; Zhou J; Ren F; Sun Y; Wang H; Huang R
Bioengineered; 2021 Dec; 12(1):1964-1975. PubMed ID: 34027794
[TBL] [Abstract][Full Text] [Related]
20. TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.
Jain M; Zhang L; He M; Zhang YQ; Shen M; Kebebew E
Endocr Relat Cancer; 2013 Jun; 20(3):361-70. PubMed ID: 23533247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
